Search
Ginkgo Bioworks Holdings Inc
DNAAdd to Watchlist
10.250USD
+1.670+19.46%
Close 09-24 16:00（ET）
638.78MMarket Cap
LossP/E TTM
After-hours 19:00 (ET)10.250USD-0.050-0.48%
After-hours 19:00 (ET)Ginkgo Bioworks Holdings Inc (DNA) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Ginkgo Bioworks Holdings Inc in the past month.
Sell
0 Strong Buy
1 Buy
0 Hold
1 Sell
1 Strong Sell
Target Price
7.000USD-18.41%
DNA Analyst Recommendation Trends
In the current month, DNA has received 1 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. DNA average Analyst price target in the last month is 7.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
1
1
2
2
2
2
2
2
1
1
1
1
1
1
1
1
3
3
4
4
4
4
4
4
DNA Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
CRISPR Therapeutics AG
CRSP
4
9
11
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, DNA EPS is projected to reach -0.870 in FY2026Q3, following reported EPS of -0.752 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.46
-1.08
-0.91
-0.87
-1.26
Actual
-1.41
-1.39
-0.75
--
--
Surprise
+2.77%
-28.38%
+17.34%
--
--
FAQs
What is Ginkgo Bioworks Holdings Inc's expected revenue for the next quarter?
Ginkgo Bioworks Holdings Inc's expected revenue is 21.57M.
What is Ginkgo Bioworks Holdings Inc's price target?
Analysts forecast that Ginkgo Bioworks Holdings Inc's price target is USD 7.00, with the highest forecast at USD 9.00 and the lowest forecast at USD 5.00.
How have Ginkgo Bioworks Holdings IncDNA's recent earnings per share performed?
The market expectation was USD -0.75, while Ginkgo Bioworks Holdings IncDNA's earnings per share (EPS) for the previous quarter was USD -1.39. EPS for the next quarter is expected at USD -0.87.
What is the analyst rating for Ginkgo Bioworks Holdings Inc?
Based on the ratings of Ginkgo Bioworks Holdings Inc's stock from 3 analysts, most analysts support a Sell trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Sell. Please note that this is not trading advice. You still need to conduct your own analysis.